These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34510000)

  • 1. Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.
    Sauerbier A; Loehrer P; Jost ST; Heil S; Petry-Schmelzer JN; Herberg J; Bachon P; Aloui S; Gronostay A; Klingelhoefer L; Baldermann JC; Huys D; Nimsky C; Barbe MT; Fink GR; Martinez-Martin P; Ray Chaudhuri K; Visser-Vandewalle V; Timmermann L; Weintraub D; Dafsari HS;
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1313-1318. PubMed ID: 34510000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
    Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS;
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.
    Dafsari HS; Petry-Schmelzer JN; Ray-Chaudhuri K; Ashkan K; Weis L; Dembek TA; Samuel M; Rizos A; Silverdale M; Barbe MT; Fink GR; Evans J; Martinez-Martin P; Antonini A; Visser-Vandewalle V; Timmermann L; ;
    Brain Stimul; 2018; 11(4):904-912. PubMed ID: 29655586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
    Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological Correlates of Trait Impulsivity in Parkinson's Disease.
    Ricciardi L; Fischer P; Mostofi A; Tinkhauser G; Torrecillos F; Baig F; Edwards MJ; Pereira EAC; Morgante F; Brown P
    Mov Disord; 2021 Sep; 36(9):2126-2135. PubMed ID: 33982824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Ashkan K; Sachse L; Mahlstedt P; Silverdale M; Rizos A; Strack M; Jost ST; Reker P; Samuel M; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Timmermann L;
    J Neurol; 2020 Jun; 267(6):1830-1841. PubMed ID: 32152689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
    Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
    J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.
    Dafsari HS; Reker P; Stalinski L; Silverdale M; Rizos A; Ashkan K; Barbe MT; Fink GR; Evans J; Steffen J; Samuel M; Dembek TA; Visser-Vandewalle V; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Timmermann L;
    Mov Disord; 2018 Jan; 33(1):99-107. PubMed ID: 29150860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson's disease.
    Sauerbier A; Herberg J; Stopic V; Loehrer PA; Ashkan K; Rizos A; Jost ST; Petry-Schmelzer JN; Gronostay A; Schneider C; Visser-Vandewalle V; Evans J; Nimsky C; Fink GR; Antonini A; Martinez-Martin P; Silverdale M; Weintraub D; Schrag A; Ray Chaudhuri K; Timmermann L; Dafsari HS;
    NPJ Parkinsons Dis; 2024 Jun; 10(1):114. PubMed ID: 38851717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.
    Dafsari HS; Weiß L; Silverdale M; Rizos A; Reddy P; Ashkan K; Evans J; Reker P; Petry-Schmelzer JN; Samuel M; Visser-Vandewalle V; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Brain Stimul; 2018; 11(4):867-874. PubMed ID: 29655587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    Choi JH; Kim HJ; Lee JY; Yoo D; Im JH; Paek SH; Jeon B
    PLoS One; 2019; 14(8):e0221219. PubMed ID: 31454366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-motor effects of deep brain stimulation in Parkinson's disease motor subtypes.
    Jost ST; Konitsioti A; Loehrer PA; Ashkan K; Rizos A; Sauerbier A; Dos Santos Ghilardi MG; Rosenkranz F; Strobel L; Gronostay A; Barbe MT; Evans J; Visser-Vandewalle V; Nimsky C; Fink GR; Silverdale M; Cury RG; Fonoff ET; Antonini A; Chaudhuri KR; Timmermann L; Martinez-Martin P; Dafsari HS;
    Parkinsonism Relat Disord; 2023 Apr; 109():105318. PubMed ID: 36842866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of bilateral subthalamic nucleus deep brain stimulation on fatigue in Parkinson's Disease as measured by the non-motor symptoms scale.
    Lazcano-Ocampo C; van Wamelen D; Samuel M; Silverdale M; Rizos A; Sauerbier A; Koch J; Podlewska A; Leta V; Dafsari HS; Timmermann L; Ashkan K; Ray Chaudhuri K
    Br J Neurosurg; 2024 Jun; 38(3):712-715. PubMed ID: 34357840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulsive-compulsive behaviors in parkin-associated Parkinson disease.
    Morgante F; Fasano A; Ginevrino M; Petrucci S; Ricciardi L; Bove F; Criscuolo C; Moccia M; De Rosa A; Sorbera C; Bentivoglio AR; Barone P; De Michele G; Pellecchia MT; Valente EM
    Neurology; 2016 Oct; 87(14):1436-1441. PubMed ID: 27590295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson's Disease.
    Samura K; Miyagi Y; Kawaguchi M; Yoshida F; Okamoto T; Kawashima M
    Neurol Med Chir (Tokyo); 2019 Sep; 59(9):331-336. PubMed ID: 31231086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.